Patents by Inventor Baptiste Vergnes

Baptiste Vergnes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protozoan strains of reduced virulence and use thereof
    Patent number: 7732188
    Abstract: The present invention relates to a protozoan strain of the family of the Trypanosomatidae the virulence of which is lower than that of the corresponding wild-type strain, characterized in that at least one copy of the SIR2 gene present in the genome of the strain is inactivated.
    Type: Grant
    Filed: October 25, 2004
    Date of Patent: June 8, 2010
    Assignees: Institut de Recherche pour le Developpement, Universidade Do Porto
    Inventors: Anabela Cordeira Da Silva, Ali Ouaissi, Denis Sereno, Baptiste Vergnes
  • Pharmaceutical Compositions For The Treatment Of Leishmaniasis
    Publication number: 20080039430
    Abstract: The present invention relates to the use of at least one compound of the following general formula (I): wherein R represents OH or NH2, or of precursors or derivatives thereof, or of the pharmaceutically acceptable salts of the compound or of its precursors or derivatives, for the manufacture of a medicament intended for the prevention or the treatment of parasitic diseases, in particular of protozoan parasitic diseases, more particularly of leishmaniosis, and especially for the prevention or the treatment of parasitic diseases occurring in immunodepressed patients.
    Type: Application
    Filed: July 15, 2005
    Publication date: February 14, 2008
    Inventors: Ali Ouaissi, Denis Sereno, Baptiste Vergnes
  • Protozoan Strains of Reduced Virulence and Use Thereof
    Publication number: 20070224224
    Abstract: The present invention relates to a protozoan strain of the family of the Trypanosomatidae the virulence of which is lower than that of the corresponding wild-type strain, characterized in that at least one copy of the SIR2 gene present in the genome of the strain is inactivated.
    Type: Application
    Filed: October 25, 2004
    Publication date: September 27, 2007
    Inventors: Anabela Cordeira Da Silva, Ali Ouaissi, Denis Sereno, Baptiste Vergnes